Positron-emitting radiopharmaceuticals are required for positron emission tomography (PET), an imaging technology, and the standards of purity for these drugs are defined by the USP. Flumazenil C 11 Injection is a radiopharmaceutical for PET imaging of benzodiazepine (BZP) receptor binding in the living human brain. ["CjFlumazenil has been shown to be especially useful for noninvasive assessment of various forms of epilepsy and drug challenge studies. The preparation and compounding of this drug is discussed, as well as its purification and quality control testing.
|Number of pages||6|
|State||Published - 1998|